According to Inotiv's latest financial reports and stock price the company's current Operating Margin is -61.26%. At the end of 2022 the company had an Operating Margin of -58.93%.
Year | Operating Margin | Change |
---|---|---|
2022 | -58.93% | -776.83% |
2021 | 8.71% | -272.74% |
2020 | -5.04% | 1426.74% |
2019 | -0.33% | -534.91% |
2018 | 0.08% | -98.57% |
2017 | 5.29% | -138.03% |
2016 | -13.92% | -325.49% |
2015 | 6.17% | -363.9% |
2014 | -2.34% | -135.89% |
2013 | 6.52% | -132.4% |
2012 | -20.11% | -613.23% |
2011 | 3.92% | -156.51% |
2010 | -6.94% | -52.05% |
2009 | -14.46% | -315.85% |
2008 | 6.70% | 26.85% |
2007 | 5.28% | -166.44% |
2006 | -7.95% | -367.52% |
2005 | 2.97% | 334.71% |
2004 | 0.68% | -74.5% |
2003 | 2.68% | -56.3% |
2002 | 6.14% | -55.57% |
2001 | 13.81% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -234,760.00% | 383,119.07% | Bahamas |
NRC Health
NRC | 32.86% | -153.64% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.